Nebion

Silver Sponsor

Immunai is a biotech company that combines single-cell multi-omics technologies with machine learning to map the immune system with unprecedented accuracy and precision. This approach enables novel insights into immune processes advancing the discovery of the next generation of immunomodulatory drugs to treat patients suffering from immune-related diseases such as cancer and autoimmune diseases.